hydroxychloroquine has been researched along with Lichen Sclerosis in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with dermatological conditions developed retinal toxicity after treatment with hydroxychloroquine that exceeded dosing recommendations." | 1.48 | Hydroxychloroquine retinal toxicity in two patients with dermatological conditions. ( Baker, C; Kowalski, T; Mack, HG, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalski, T | 1 |
| Baker, C | 1 |
| Mack, HG | 1 |
| García-Doval, I | 1 |
| Peteiro, C | 1 |
| Sánchez-Aguilar, D | 1 |
| Toribio, J | 1 |
2 other studies available for hydroxychloroquine and Lichen Sclerosis
| Article | Year |
|---|---|
Hydroxychloroquine retinal toxicity in two patients with dermatological conditions.
Topics: Aged; Antimalarials; Female; Humans; Hydroxychloroquine; Lichen Planus; Lichen Sclerosus et Atrophic | 2018 |
Extensive bullous lichen sclerosus et atrophicus unresponsive to hydroxychloroquine.
Topics: Aged; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Lichen Sclerosus et Atrophicus | 1996 |